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Abstract: As a coagulase negative Staphylococcus species, S. caprae is not considered as a clinically-significant member, 
unlike S. epidermidis. In this report, we describe a case of sepsis resulting from S. caprae infection. This relatively young 
woman was in generally good health and contracted S. caprae most probably during her treatment of an acute pulmonary 
embolism. The purpose of this report is to raise awareness of this otherwise innocuous staphylococcal species in clinical 
settings. 
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INTRODUCTION 
  Coagulase negative staphylococci are one of the most 
common nosocomial agents for causing infections in 
healthcare facilities [1, 2]. Among the species, S. caprae has 
not been a concern in human clinical cases. It was first   
isolated in milk sample taken from healthy goats in 1983 [3]. 
Since then, this bacterium is considered a commensal organ-
ism in goats as it is most prevalent on their udder skins and 
in the mammary glands. 
 Strains  of  S. caprae have been isolated from human 
cases; however, it was not always clear whether this organ-
ism was responsible for causing infections [4, 5]. This bacte-
rium has been associated with bone and joint infections,   
bacteremia, recurring sepsis, urinary infections, endocarditis, 
meningitis, and cases of acute otitis externa [2, 4-9]. Most of 
these infections were contracted in the hospitals, and a few 
community-acquired have also been reported. A recent paper 
reported  S. caprae was responsible for causing six out   
of eighteen episodes of coagulase negative staphylococcal 
bacteremia in the neonatal intensive care unit of a medical 
institution [2].  
CASE PRESENTATION 
  A 30-year old African American woman presented to the 
emergency department complaining of shortness of breath   
on exertion and chest pain with deep inspiration. Otherwise, 
the patient stated she was well. There was no indication of 
recent infections. 
  Her physical examination did not yield any abnormalities 
or concerns. A VQ scan indicated high probability for   
pulmonary emboli in her right lobe. The chest x ray showed 
possible development of small bilateral pleural effusions. 
Multiple nodular opacities scattered throughout the lungs 
were also noted and they seemed to be more prominent than  
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before. The CT scan of the abdomen showed moderate   
alveolar consolidation in the right lower lobe which was   
consistent with a pulmonary infarct or pneumonia. Her EKG 
and 2D echocardiograms were normal and there was no   
indication of endocarditis. 
  The patient was admitted for treatment of an acute   
pulmonary embolism and a Heparin drip, by protocol, was 
initiated. While the management of her pulmonary embolism 
was proceeding well, the patient developed high fevers   
during her hospital stay associated with tachycardia. Her 
blood cultures were positive (four out of four bottles), 
yielded Gram positive cocci in pairs and clusters indicative 
of  Staphylococcus species. Subsequent identification by 
Vitek 2 GP card (bioMérieux, MO) indicated the bacterium 
was S. caprae. Antibiotic susceptibility results of this isolate 
are presented below. 
Antimicrobial Agents  Result (mm)  Interpretation 
Ampicillin 22  Resistant 
Ampicillin/Sulbactam 27  Sensitive 
Clindamycin 28  Sensitive 
Cephalothin 35  Sensitive 
Erythromycin 33 Sensitive 
Gentamcin 31  Sensitive 
Imipenem 53  Sensitive 
Oxacillin 20  Sensitive 
Penicillin 19  Resistant 
Rifampin 35  Sensitive 
 
  The patient was initially started on vancomycin. When S. 
aureus was ruled out, her antibiotics were changed to Kefzol 
2 gm IV every 8 hours. The patient’s fever resolved and   
she showed significant clinical improvement. Incidentally, a 
urinalysis indicated the presence of E. coli. Antibiotic   
susceptibility testing indicated it was sensitive to all 17   
antimicrobial agents in the panel (Vitek E. coli panel). Three 68    The Open Microbiology Journal, 2009, Volume 3  Kini et al. 
days of Ciprofloxacin was administered to treat the urinary 
tract infection. 
  Echocardiogram did not reveal any evidence of   
endocarditis, and it is unclear what caused the infection. 
There was no indication that the patient recently visited a 
farm or had contact with goats, the likely sources to acquire 
this bacterium. Other risk factors reported to be associated 
with S. caprae infection such as transplants, internal fixation 
for orthopedic prosthesis, or foreign subject implants [4, 5, 7, 
9] were not in the patient’s medical history.  
COMMENTS 
  It is conceivable that the patient contracted S. caprae 
during her hospital stay, as this bacterium has been impli-
cated in several nosocomial infections [1, 5]. S. caprae had 
been misidentified in the past [2, 6, 7, 10], which suggest 
there are probably more cases associated with this bacterium 
than previously reported. In this case report, the identity of  
S. caprae was established by the current Vitek 2 GP system 
which allows more reliable identification of the caprae  
species than previous versions [personal communication with 
bioMérieux]. Additionally, this isolate produced acid from 
mannitol and was urease positive, two important biochemical 
traits recommended for differentiating this species from 
other coagulase negative staphylococcal members [10].  
  In conclusion, clinicians should be cognizant of infec-
tions caused by S. caprae, particularly in hospital settings 
and healthcare facilities. Although this species has been   
regarded as innocuous in the past, it should not be dismissed 
readily especially when isolated from the elderly and   
immunocompromised patients. Some S. caprae strains have 
acquired methicillin resistance, and their ability to persist in 
the environment for a long time (i.e., 28 months or more) has 
been reported [2, 6]. Furthermore, slime production and 
biofilm formation are traits of S. caprae and they may play a 
role in conferring virulence to this species [11, 12]. All these 
properties of S. caprae are certainly reasons for healthcare 
professionals to be concerned and keep vigilance. Therefore, 
early detection and accurate identification of this bacterium 
will help preventing serious complications that may result 
from the colonization and invasion of this skin flora. 
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